Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02045082
Other study ID # DR-002-1399, 2012-1649
Secondary ID
Status Terminated
Phase Phase 4
First received January 21, 2014
Last updated February 25, 2016
Start date October 2013
Est. completion date October 2015

Study information

Verified date January 2016
Source Centre Hospitalier Universitaire de Québec, CHU de Québec
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare a corneal sampling realized by a flocked swab (flocked swab regular 519CS01) with a sampling by traditional fiber swab (Copan regular swab 164KS01 in polyester). Their impact on the sensibility of the viral culture in the Herpes simplex epithelial keratitis will be the primary objective of this study.


Description:

In our center, the flocked swabs became an important tool in the corneal sampling for viral keratitis, replacing rightly or wrongly the former traditional fibers swab. No research was specifically designed to study the corneal taking with these swabs. Nevertheless, numerous reasons would motivate it, because of the peculiarities in ophthalmology: the corneal sampling has to be made with the slit lamp rather than in a macroscopic manner; the corneal lesion are often millimetre-length and confined; the histology of the cornea is unique and compares only imperfectly with other structures of the human body like the nasal mucosa. In these circumstances, the properties of the stalk (rigidity, length) and of its extremity (roughness, textures, absorbance) can influence the quality of the sampling and the final result of the culture.


Recruitment information / eligibility

Status Terminated
Enrollment 146
Est. completion date October 2015
Est. primary completion date October 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Slit lamp signs at the initial examination that are compatible with an Herpes simplex epithelial keratitis (Herpes simplex dendrite, herpes simplex geographic ulcer)

Exclusion Criteria:

- Topical or systemic antiviral Therapy during the last 14 days Patient with Herpes simplex stromal keratitis without epithelial involvement Herpetic lesion outside the cornea

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Diagnostic


Intervention

Procedure:
Corneal sampling
Slit lamp corneal sampling with a Swab

Locations

Country Name City State
Canada Centre universitaire d'ophtalmologie, Hôpital du Saint-Sacrement, CHU de Québec Québec Quebec

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Québec, CHU de Québec

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Result of the culture The result can be Positive or negative for Herpes simplex virus (HSV). Even if the result will be available in less than 1 week by the clinician after the culture, the research team will collect the data 1 month in average after the initial visit. 1 month after the initial visit No
Secondary Time before positivity of the culture If the culture is positive for Herpes simplex virus, what is the time lapse(in day) before the culture became positive. The research team will collect the data 1 month in average after the initial visit by examining the microbiologic data of the laboratory. 1 month after the initial visit No
Secondary Viral load concentration Quantitative polymerase chain reaction (PCR) will be on a part of the sampling 1 month after the initial visit. The result will be the concentration of virus in number/ml detected in the sampling 1 month after the initial visit No
See also
  Status Clinical Trial Phase
Completed NCT00357812 - The Efficacy of Two Potential Diagnostic Assays for Herpes Simplex Keratitis (HSK) Phase 1
Recruiting NCT03217474 - Femtosecond Laser-assisted Corneal Debridement for Herpes Simplex Keratitis N/A